FGP
GMED icon

Freestone Grove Partners’s Globus Medical GMED Stock Holding History

Freestone Grove Partners’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-212,109
Closed -$18.5M – 1067
2025
Q4 		$18.5M Buy
+212,109
New +$16.1M 0.13% 220
2025
Q3 		– Sell
-389,936
Closed -$23M – 786
2025
Q2 		$23M Buy
389,936
+31,893
+9% +$2.06M 0.17% 184
2025
Q1 		$26.2M Buy
358,043
+281,990
+371% +$23.3M 0.27% 140
2024
Q4 		$6.29M Buy
+76,053
New +$6M 0.08% 229

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Freestone Grove Partners's GMED Position: Q1 2026 in Review

Freestone Grove Partners sold out of Globus Medical (GMED) in Q1 2026, closing a stake of 212,109 shares — an estimated $18.5M sold.

Freestone Grove Partners first reported a position in GMED in Q4 2024 and held it in 4 quarters. The position peaked at $26.2M in Q1 2025. 610 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

  • Freestone Grove Partners reported no remaining Globus Medical position as of Q1 2026 after selling out during the quarter.
  • Freestone Grove Partners sold 212,109 Globus Medical shares in Q1 2026, an estimated $18.5M.
  • Freestone Grove Partners first reported a position in Globus Medical in Q4 2024 and held it in 4 quarters.
  • Freestone Grove Partners's Globus Medical position peaked at $26.2M in Q1 2025.
  • 610 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Freestone Grove Partners's 13F filing for Q1 2026, filed 15 May 2026.